Literature DB >> 10021449

Supply-side and trickle-down therapy.

G A Grabowski1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10021449      PMCID: PMC408110          DOI: 10.1172/JCI6290

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Inhibitors and stimulators of glucocerebroside metabolism.

Authors:  N S Radin
Journal:  Prog Clin Biol Res       Date:  1982

4.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.

Authors:  Y Liu; R Wada; H Kawai; K Sango; C Deng; T Tai; M P McDonald; K Araujo; J N Crawley; U Bierfreund; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.

Authors:  K Sango; S Yamanaka; A Hoffmann; Y Okuda; A Grinberg; H Westphal; M P McDonald; J N Crawley; K Sandhoff; K Suzuki; R L Proia
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.